CBG

Cannabinoids Show Promising Anti-Cancer Potential Yet Mechanisms Remain Unclear, New Study

Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion

First-Ever Human Trial Finds CBG Reduces Anxiety And Boosts Memory

Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion

First-Ever Human Trial Finds CBG Reduces Anxiety And Boosts Memory

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country

Vegan Gummies With CBD, CBN & CBG Launching In Canada, Here's Where To Find Them

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country

Vegan Gummies With CBD, CBN & CBG Launching In Canada, Here's Where To Find Them

What Are Cannabinoids, Their Types, And Effects?

CBG: The 'Mother Cannabinoid' May Hold Key To Treating Nonalcoholic Fatty Liver Disease Symptoms

CBG Recent News

Cannabis With Enhanced Amounts Of THC (17%), CBG (25%) And Terepens (30%): Researchers Found A Way To Do It

This article was originally published in May 2022. Can cannabinoid content in the cannabis plant be manipulated? And if so, how much?

CBG Mania - What Are The Best Ways To Use And Consume CBG

This article was originally published on Cannabis.net and appears here with permission. Cannabigerol (CBG) is quickly becoming one of the most popular cannabinoid products these days.

7 Emerging Cannabinoids To Watch

This article was originally published on NisonCo and appears here with permission.

Radicle Science To Conduct Large-Scale Clinical Trials On Rare Cannabinoids - THCV, CBN, CBG, And CBC

Radicle Science will launch large-scale, blinded, placebo-controlled clinical trials on rare cannabinoids including THCV, CBN, CBG, and CBC, to study their effects on energy, focus, appetite, sleep disturbance, pain, stress, and anxiety. These unprecedented Radicle Discovery studies will involve more than 10,000 participants and are set to kick

Is The Cannabis Market Ready For Lab-Grown Cannabinoids?

Much of cannabis’ disruptive potential lies in the plant’s ability to produce cannabinoids like THC and CBD. When it comes to rare cannabinoids, however, a different approach might yield better results.

Willow Biosciences Touts Strong Q3 Results, Continues Its Focus On Biosynthetically Produced Cannabinoids

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) released its third-quarter financial and operating results Monday, revealing it has ended the quarter in a strong financial position, with approximately $35.7 million i

Cronos Group & Ginkgo Bioworks Launch First Cultured Cannabinoid Product: A THC & CBG Infused Gummy

On Wednesday, the Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced the launch of what it is calling the first cannabis edible in Canada to contain THC and cultured cannabigerol (CBG) from fermentation in a sweet gummy f

Cronos Group, Ginkgo Bioworks Modify Agreement To Speed Up Commercialization of Cultured Cannabinoids

Cannabinoid company Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is amending its previous partnership agreement with Ginkgo Bioworks, Inc., a company involved in cell programming.

Fintech Focus For April 30, 2021

Quote To Start The Day: “My fantasy is to break up the big banks. I wish we would end 'too big to fail' in our banking system.”

CBG, The Mother Of Cannabinoids, Is In The Spotlight

This article by Camila Ferezin was originally published on The Green Fund, and appears here with permission.

Cannabis Movers & Shakers: Next Green, Cannabis Control Commission, Willow, TruTrace, HEXO, Bengal Capital, MediPharm Labs

Here is a summary of the latest leadership changes within the cannabis industry.

Kannaway Debut's On European CBG Market

Kannaway made its debut on the European cannabigerol (CBG) market on Thursday by its parent company Medical Marijuana Inc. (PINK: MJNA).

Primo Nutraceuticals To Acquire Agritek's Full Spectrum Biosciences

Primo Nutraceuticals Inc.

Organigram Invests In Hyasynth Biologicals, Parts Ways With Executives

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has invested an additional $2.5 million in a private biotechnology company Hyasynth Biologicals Inc.

Tauriga Teams Up With Willie Mack And CJ Wallace To Develop New CBD, CBG Products

Tauriga Sciences Inc. (OTCQB: TAUG) and Los Angeles-based Think Big LLC entered into a licensing deal to launch a range of co-branded CBD and CBG products.

Avicanna Exports CBG, CBD Into US, Germany

Biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) said Monday that it has finalized exports of CBG and CBD isolates into the United States through its Colombian subsidiary Santa Marta Golden Hemp S.A.S.

Double Down CBD Launches Product Line With Proprietary Extraction Tech

Double Down CBD announced Wednesday its entry into the CBD and CBG market with its organic hemp extracts, developed via a patent-pending extraction technology and process.

'The Next Big Thing': How Cannabigerol (CBG) May Revolutionize the Cannabis industry

Cannabis 101: CBG Or Cannabigerol, The Next CBD?

High Grade Hemp Seed Introduces New CBG Hemp Strain To US Farmers

Cannabinoids 101: What's CBG And What Does This Marijuana Compound Help Heal?

;